Life-saving R & D

logo cream

Since its inception, UKTS has sponsored a multitude of research projects. In fact, the life-changing oral chelator, Deferiprone, was funded and supported directly by the UKTS. To name but a few, we have also funded research into: the development of an in-utero approach for thalassaemia gene therapy; liver fibrosis; bone disease treatments; prognostic value of MRI imaging; and the study of psychosocial issues and impacts of transition from childhood to adulthood of adolescents with thalassaemia.